Blueberries Medical

Blueberries Medical EBITDA per Employee

EBITDA per Employee of Blueberries Medical (BBM.CN) as of Nov 2, 2026.

EBITDA per Employee

-CAD

Last updated:

EBITDA per Employee of Blueberries Medical is 2026 - CAD. EBITDA per Employee of Blueberries Medical was 2025 - CAD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Blueberries Medical Stock analysis

What does Blueberries Medical do? Blueberries Medical Corp. generates revenue through the production and distribution of psychoactive and non-psychoactive cannabis by-products, focusing on medicinal cannabis and related products. The company develops and supplies medicinal-grade Cannabis oil extracts, medical flowers, and cannabis-derived ingredients such as high and low THC, CBD, and other cannabinoids. Its subsidiaries, including Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc., and SATIN S.A.S., operate in Colombia as licensed producers and distributors of medicinal cannabis products. Blueberries SAS specifically handles the cultivation, growth, and development of medicinal cannabis within Colombia's regulatory framework. The primary buyers of Blueberries Medical Corp.'s products are medical cannabis consumers and healthcare providers seeking medicinal-grade cannabis extracts and derivatives. The company serves the medicinal cannabis segment, targeting patients requiring therapeutic treatments through non-psychoactive and psychoactive cannabis products. Blueberries Research Corporation (BRC) supports the development of new cannabis-derived ingredients, while BBV Labs focuses on processing and commercializing these products for medical use. Blueberries Medical Corp. operates through its subsidiaries to manage cultivation, processing, and distribution across Colombia. The firm's product portfolio includes medicinal-grade Cannabis oil extracts, medical flowers, and cannabinoid-based ingredients, which are supplied to the medical cannabis market. Blueberries SAS, as a licensed producer, ensures compliance with Colombian regulations while distributing products to healthcare providers and patients requiring medicinal cannabis solutions. Blueberries Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Blueberries Medical stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Blueberries Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Blueberries Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Blueberries Medical

All Key Metrics — Blueberries Medical